HOME Press Releases Continuous Renal Replacement Therapy (CRRT) Market worth 1.53 Billion USD by 2022



Continuous Renal Replacement Therapy (CRRT) Market worth 1.53 Billion USD by 2022


The report "Continuous Renal Replacement Therapy (CRRT) Market by Product (Systems, Disposables (Hemofilters & Bloodlines), & Dialysate), Modality (SCUF, CVVH, CVVHD, CVVHDF), Adoption & Procedures, and Region (Europe, North America, Asia-Pacific) - Forecast to 2022", The global CRRT market is projected to reach USD 1.53 Billion by 2022 from USD 1.09 Billion in 2017, at a CAGR of 7.0%. analyzes and studies the major drivers, restraints, opportunities, and challenges of the CRRT market in North America, Europe, Asia-Pacific, and the Rest of the World (RoW).

                                              Request Sample                     Request Sample

Browse 65 Market Data Tables and 51 Figures spread through 188 Pages and in-depth TOC on "Continuous Renal Replacement Therapy (CRRT) Market by Product (Systems, Disposables (Hemofilters & Bloodlines), & Dialysate), Modality (SCUF, CVVH, CVVHD, CVVHDF), Adoption & Procedures, and Region (Europe, North America, Asia-Pacific) - Forecast to 2022"
https://www.marketsandmarkets.com/Market-Reports/continuous-renal-replacement-therapy-market-246917088.html
Early buyers will receive 10% customization on reports.

Factors such as increasing global incidence of acute kidney injury, increasing incidence of sepsis, growing prevalence of diabetes, and hypertension are driving the growth of the market.

Disposables product segment poised to grow fastest in CRRT market

On the basis of product, the CRRT market is segmented into CRRT systems, disposables, and dialysates & replacement fluids. The disposables segment is expected to register highest CAGR during the forecast period mainly due to the large and regular demand for consumables owing to their short work life.

Continuous venovenous hemodiafiltration (CVVHDF) segment is expected to register fastest growth rate during the forecast period

Based on modality, the CRRT market is segmented into slow continuous ultrafiltration (SCUF), continuous venovenous hemofiltration (CVVH), continuous venovenous hemodialysis (CVVHD), and continuous venovenous hemodiafiltration (CVVHDF). CVVHDF segment is projected to register the highest CAGR due to benefits of convection and diffusion for the removal of solutes (which combines filtration and dialysis processes for the removal of small to medium-sized molecules).

Europe is estimated to account for the largest share of the CRRT market

Geographically, the CRRT market is segmented into North America, Europe, Asia-Pacific, and the Rest of the World. Asia-Pacific is expected to grow at the highest CAGR during the forecast period due to the increasing incidence of acute kidney injuries.

The major players in the market are Baxter International Inc. (U.S.), Fresenius Medical Care AG & Co. KGaA (Germany), Nikkiso Co., Ltd. (Japan), B. Braun Melsungen AG (Germany), Bellco S.r.l. (Italy), NxStage Medical, Inc. (U.S.), Asahi Kasei Corporation (Japan), Infomed SA (Switzerland), Medica S.p.A. (Italy), and Toray Medical Co., Ltd. (Japan).

About MarketsandMarkets™

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 5000 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets’s flagship competitive intelligence and market research platform, "RT" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Contact:
Mr. Rohan
MarketsandMarkets™
701 Pike Street,
Suite 2175, Seattle,
WA 98101, United States
1-888-600-6441
Email: sales@marketsandmarkets.com

Connect Us

Follow us on LinkedIn  Follow us on Facebook   Follow us on Twitter 
Live Chat Support


US : 1-888-600-6441

Search reports